BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 12285566)

  • 1. Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
    Rubio-lotvin B; Ruiz-moreno JA; Gonzalez-ansorena R
    Adv Contracept Deliv Syst; 1992; 8(1-2):75-88. PubMed ID: 12285566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Triella: a French multicenter double blind clinical study].
    Castaigne JP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):445-53. PubMed ID: 12280213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the triphasic oral contraceptive on lipid and lipoprotein metabolism.
    Kirumbi LW; Maina FW; Sekadde Kigondu CB; Mati JK
    J Obstet Gynaecol East Cent Africa; 1991; 9(1):23-9. PubMed ID: 12316812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestodene: clinical experience with an innovative progestogen used in a combination oral contraceptive preparation.
    Merchiers E; Thiery M; Van Kets H; Parewijck W; Defoort P; Martens G
    Acta Ther; 1990; 16(2):129-38. PubMed ID: 12342969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three triphasic oral contraceptives now available in U.S.
    Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative clinical study of the effects of three types of low-dose estrogen/progestogen oral contraceptives].
    Chen JK
    Shengzhi Yu Biyun; 1987 May; 7(2):11-6. PubMed ID: 12268918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The triphasic pill].
    Belaisch J
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):368-72. PubMed ID: 12280209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
    Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
    Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical overview of a new triphasic contraceptive containing gestodene.
    Christie T
    Int J Fertil; 1989 Sep; 34 Suppl():40-9. PubMed ID: 2576257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral contraception with Moneva: findings of a cohort study of 6000 women].
    Szapiro N
    C R Ther Pharmacol Clin; 1993; (112):3-7. PubMed ID: 12318672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and safety of a new combined oral contraceptive containing 75 micrograms gestodene and 30 micrograms ethinyl estradiol in Mexican women].
    Martinez M; Perez Palacios G; Garza Flores J; Bassol S; Recio R
    Invest Med Int; 1990; 17(1):3-9. PubMed ID: 12283863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of some coagulation tests in women using low dosage oral contraception].
    Gramolini R; Perrone G; Calzolari E; Mancone M; Masci A; Materazzi P; Serafini P; Zichella L
    Patol Clin Ostet Ginecol; 1987; 15(5):307-12. PubMed ID: 12282061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
    Benagiano G
    Int J Fertil; 1989 Sep; 34 Suppl():31-9. PubMed ID: 2576255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some aspects of studies with oral contraceptives in Indian women.
    Shah PN
    J Obstet Gynaecol India; 1966 Aug; 16(4):409-14. PubMed ID: 12262163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.